In the Medicare population, immunohistochemistry use increased from 11% of melanoma cases diagnosed in 2000 to half of melanoma cases diagnosed in 2017, with considerable variation in use and trends across regions of the U.S. https://ja.ma/4cZP4fy
JAMA Dermatology
Book and Periodical Publishing
Chicago, Illinois 10,493 followers
A member of the JAMA Network, which includes JAMA, 11 specialty journals, and JAMA Network Open.
About us
JAMA Dermatology is published online weekly, every Wednesday, and in 12 print/online issues a year. The journal receives more than 7.2 million annual article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. The journal's acceptance rate is 10%. The median time to first decision is 4 days, and 47 days with review. The Journal Impact Factor is 10.9, one of the highest ranking among dermatology journals. All articles are published online first. Kanade Shinkai, MD, PhD, UCSF Department of Dermatology, San Francisco, California, is the editor in chief.
- Website
-
https://jamanetwork.com/journals/jamadermatology
External link for JAMA Dermatology
- Industry
- Book and Periodical Publishing
- Company size
- 5,001-10,000 employees
- Headquarters
- Chicago, Illinois
- Founded
- 1882
- Specialties
- Dermatology
Updates
-
Most viewed in the last 7 days from JAMA Dermatology: Can calcitonin gene-related peptide-inhibition improve rosacea-associated erythema and flushing, and is it safe? https://ja.ma/3UhtgUf
-
-
The findings of this study suggest that sequential fat grafting with fresh fat and cryopreserved stromal vascular fraction gel has therapeutic potential for treating morphea. https://ja.ma/3W2BAcR
-
This meta-analysis examines demographic and tumor characteristics and treatment approaches for different extramammary Paget disease subtypes and presents recommendations for diagnosis and treatment. https://ja.ma/49HYWb0
Anatomic Subtype Differences in Extramammary Paget Disease
jamanetwork.com
-
This Viewpoint discusses the need for a broader approach to nail pathology, in which infectious, inflammatory, systemic, and structural factors are considered. https://ja.ma/44lqNg8
Rethinking the Approach to Nail Disorders
jamanetwork.com
-
Most viewed in the last 7 days from JAMA Dermatology: Can calcitonin gene-related peptide-inhibition improve rosacea-associated erythema and flushing, and is it safe? https://ja.ma/3xUL3ci
-
-
Case report describes an adult male patient with a severe acneiform eruption on his chest and back. On physical exam, he was noted to have diffuse acneiform papules on the trunk and was incidentally noted to have anomalous elongation of the eyelashes. https://ja.ma/44m1iLx
-
-
Most viewed in the last 7 days from JAMA Dermatology: Is oral minoxidil effective in treating androgenetic alopecia in men compared with topical minoxidil, 5%? https://ja.ma/4aFFFbx
-
-
Application of the rosacea core domain set identified in this consensus statement may improve the usefulness of future research in rosacea therapies by enabling meta-analyses and other comparisons across studies. https://ja.ma/3JxQQa9
-
-
Interview with Amy Paller, MD, author of "Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders," hosted by Adewole Adamson, MD, MPP. https://ja.ma/3w7B6Yi
Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders
edhub.ama-assn.org